YieldGuard checks hospital price transparency files against the federal rule (45 CFR Part 180). Hospitals pay vendors to keep these files compliant. We check whether they got what they paid for. https://t.co/0RCf7e0N0R
Some telehealth brands are fronts: the brand markets, a separate clinical network prescribes, and a separate pharmacy fills. Our map identifies all three where public. Map: https://t.co/jsZdQklIq8
A percentage in a hospital price file does not settle whether allowed-amount statistics are required. CMS carves out fully calculable dollar charges. Applicability comes first. https://t.co/NM6wZNPPdI
Our map records each brand's ads from the public Meta and Google ad libraries, with the dates we pulled them. Ad libraries are snapshots, so we label them that way. Map: https://t.co/jsZdQkmgfG
Since January 1, 2026, hospital price files must carry dollar allowed amounts, a count, a named responsible official, and Type 2 NPIs. CMS began enforcing these on April 1. https://t.co/gkqvQixwYG
We sort the 262 brands in our map by approximate company size and by data completeness, with the basis labeled. Unknowns sink to the bottom instead of being zeroed. Map: https://t.co/jsZdQkmgfG
Across 66 large-hospital files we re-scanned, 60 had at least one rate more than 20 times the median for that code. That is a flag for the hospital to review, not proof of an error. https://t.co/NVJ7BhMLrQ
The medspa model keeps care local: clients already trust their clinic. FeelPeptides adds peptide products and protocol support to that existing relationship. https://t.co/v7FtNaZPSC
Six gap types explain most of what breaks in 2026 hospital price files: missing dollar allowed amounts, missing counts, wrong-period data, missing NPIs, old attestations, unexplained blanks. https://t.co/ai4uceQQkF
Every telehealth order ends at a pharmacy. Most brands in our map do not say which one. We think that is worth knowing, so we track it: https://t.co/jsZdQklIq8
A validator pass is not a compliance pass. The CMS validator checks a hospital price file's structure; it cannot say the data is complete or true. The rest takes a closer look. https://t.co/BKPeC6GM4Y
Our map grew from 209 brands to 262 in a week of suggestions. Every addition goes through the same screening before it joins the verified set. Map: https://t.co/jsZdQklIq8
A price and a statistic answer different questions. A negotiated charge says what the contract states; a median says what claims history shows. Identical numbers do not make them interchangeable. https://t.co/waXELWlEjD
GLP-1 is one product line for many telehealth brands, not the whole business. Our map tags what each brand actually sells - all products, not just GLP. Map: https://t.co/jsZdQkmgfG
Every hospital price file must include the discounted cash price - what a person paying out of pocket is charged. A file that skips it is missing a required field. https://t.co/gkqvQixwYG
Our telehealth map has a detail page for each of the 262 brands: products, prices, ads, the clinical network, and the pharmacy behind the brand. Free to view: https://t.co/jsZdQklIq8
Most US hospitals have a price transparency link on their homepage - we verified 70% of 5,421. A link is not a file that works. The gap between the two is where compliance lives. https://t.co/0RCf7e0N0R
FeelPeptides works through medspas because the client relationship is in person. The medspa sees the client; we supply peptide products and protocol support behind the visit. https://t.co/v7FtNaZPSC
The federal price transparency rule applies to every US hospital. Each must publish a machine-readable file of its prices and keep it current, updated at least once a year. YieldGuard checks the file you published. https://t.co/0RCf7e0N0R
This week in peptides: the EMA recommended Eli Lilly's oral GLP-1 pill Foundayo (orforglipron) for approval in the EU - a once-daily tablet, an alternative to injectables (EMA, Oct 16). Our map tracks 262 brands in this market: https://t.co/jsZdQklIq8